Erika Cavallone
Program Manager
Radiology
School of Medicine
Publications (6)
Top publication keywords:
Skin NeoplasmsNeutropeniaRegistriesNeoplasm Recurrence, LocalCognitive DysfunctionLymphoma, T-CellRetreatmentBendamustine HydrochlorideLymphoma, T-Cell, PeripheralLymphoma, Non-HodgkinLymphoma, T-Cell, CutaneousInternetAntineoplastic Combined Chemotherapy ProtocolsDepsipeptidesNeuropsychological Tests
-
Exploring the role of depression in the association between APOE ε4 and cognitive function: Evidence from the Brain Health Registry.
Journal of psychiatric research 2026 Wang Y, Ashford MT, Jin C, Cavallone E, Mackin RS, Morlett-Paredes A, Nosheny RL, George KM -
Subjective cognitive decline and objective cognitive performance across diverse intersectional identities by gender, race/ethnicity, and educational attainment.
American journal of epidemiology 2026 Chen NX, Ashford MT, Jin C, Rojas-Saunero LP, Mayeda ER, Morlett-Paredes A, Cavallone E, Farias ST, Nosheny RL, George KM -
Evaluating the Accuracy of Web-Based and In-Clinic Subjective Cognitive Decline Assessments in Detecting Cognitive Impairment: Multicohort Study.
Journal of medical Internet research 2025 Kang JM, Manjavong M, Diaz A, Ashford MT, Aaronson A, Eichenbaum J, Mackin S, Tank R, Miller MJ, Landavazo B, Cavallone E, Truran D, Camacho MR, Fockler J, Flenniken D, Farias ST, Weiner MW, Nosheny R -
Subjective cognitive decline predicts longitudinal neuropsychological test performance in an unsupervised online setting in the Brain Health Registry.
Alzheimer's research & therapy 2025 Kang JM, Manjavong M, Jin C, Diaz A, Ashford MT, Eichenbaum J, Thorp E, Wragg E, Zavitz KH, Cormack F, Aaronson A, Mackin RS, Tank R, Landavazo B, Cavallone E, Truran D, Farias ST, Weiner MW, Nosheny … -
Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial.
Clinical lymphoma, myeloma & leukemia 2020 Kambhampati S, Fakhri B, Ai WZ, Kaplan LD, Tuscano JM, Wieduwilt MJ, Sudhindra A, Cavallone E, Reiner J, Aoun C, Castillo M, Martinelli M, Ta T, Le D, Padilla M, Crawford E, Andreadis CB -
Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Vu K, Wu CH, Yang CY, Zhan A, Cavallone E, Berry W, Heeter P, Pincus L, Wieduwilt MJ, William BM, Andreadis C, Kaplan LK, McCormick F, Porcu P, Brammer JE, Ai WZ